Buy 27848-84-6 Nicergoline from Lab of wujiaren

Basic Information
 

Nicergoline, sold under the brand name Sermion among others, is an ergot derivative used to treat senile dementia and other disorders with vascular origins. Internationally it has been used for frontotemporal dementia as well as early onset in Lewy body dementia and Parkinson's dementia. It decreases vascular resistance and increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells. It has similar vasoactive properties in other areas of the body, particularly the lungs. Unlike many other ergolines, such as ergo tamine, nicergoline is not associated with cardiac fibrosis.

It is used for vascular disorders such as cerebral thrombosis and atherosclerosis, arterial blockages in the limbs, Raynaud's disease, vascular migraines, and retinopathy.

Nicergoline has been registered in over fifty countries and has been used for more than three decades for the treatment of cognitive, affective, and behavioral disorders of older people. Non-relevant or mentionable data exists on non/elderly. US maintains "Aracept" as most universally prescribed for dementia. 

Nicergoline ( Sermion ) has shown to negatively affect patterned sleep behavior, narcolepsy, muscular atrophy or spasms. All pre/dispositions affected impair memory function. Nicerlogine can reduce seizures in older patients while inducing in younger. All "dementia" related pharmacological therapies are theoretical in nature as brain death can't be determined until post mortem autopsy. All "dementia" related diagnosis are most painful for afflicted as understanding of why something isn't working out outword perception of behavior isn't registered. "Dementia" related to lobe inference and inability to process actions lead to highest risk of suicide. Similar to the non understanding of head trauma outlined within (CTE).

Medical Uses

Nicergoline is used in the following cases:

• Acute and chronic cerebral metabolic-vascular disorders (cerebral arteriosclerosis, thrombosis and cerebral embolism, transitory cerebral ischaemia). Acute and chronic peripheral metabolic-vascular disorders (organic and functional arteriopathies of the limbs), Raynaud's disease and other syndromes caused by altered peripheral irrigation.
• Migraines of vascular origin
• Coadjutant therapy in clinical situations accompanied by platelet hyper-aggregability, arterial tension.
• Corio-retinal vascular disorders: diabetic retinopathy, macular degeneration and retinal angiosclerosis
• Oto-vestibular problems of a vascular nature: dizziness, auditory hallucinations, hypoacusis.

Our Company
Wuhan Wujia Trading Co.,Ltd is a high-tech innovative enterprise specializingin the R & D, production and sales of API and pharmaceutical intermediates(excluding drugs). Our company is based on the optical valley biologicalcity, with the help of Wuhan University Scientific Research Laboratory,making full use of the park policy advantages, focusing on the researchand development of biological medicine. Our company always adheres to thebusiness philosophy of "market demand oriented; technology researchand development as the core competitiveness; e-commerce as the platform",more accurate, better, faster and more reliable to provide biomedical productsfor pharmaceutical units, university scientific research institutions,hospital outpatient service, reagent units, distributors in the world.